Bullish option flow detected in Viking Therapeutics (VKTX) with 61,052 calls trading, 8x expected, and implied vol increasing over 32 points to ...
CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...
As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.
Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...
The stock of AppLovin ($APP) is down 11% after short-seller Edwin Dorsey accused the mobile technology company of committing ...
11h
TipRanks on MSNPalantir Stock Drops 13% in Five Days, Let’s Look at Who Owns PLTRSoftware company Palantir Technologies ($PLTR) stock has been sliding recently due to several concerns. The stock has dropped around 13% in the ...
Rumors of a Microsoft Surface Duo 3 excited me about another version, but Microsoft gave up on the project. I doubt I would’ve enjoyed the leaked Duo 3, as Microsoft reportedly planned a more ...
He said that hedge fund ownership of potential deregulation beneficiaries, stocks with small business exposure, and domestic ...
Akamai's stock was plunging 20.8% in recent trading toward a two-year low, and its worst day in 17 years, after the cybersecurity and cloud services company provided a downbeat earnings outlook, and ...
Read here for VSE Corporation's 2023-24 growth, key M&A moves, and Fleet Business sale analysis. Learn why caution persists ...
We recently compiled a list of the 12 Best Most Active Stocks to Buy Now. In this article, we are going to take a look at ...
Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results